To the best of our knowledge, the relationship of functional recovery with genetic profile in MS has been investigated only in two studies focused on BDNF Val66Met polymorphism [23] and on cannabinoid receptor polymorphisms [24]. The gene discussed is BDNF; the disease is myeloid sarcoma.